Literature DB >> 7681589

A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains.

S Ahmad1, D Banville, Z Zhao, E H Fischer, S H Shen.   

Abstract

A cDNA encoding a nontransmembrane protein-tyrosine phosphatase (PTP; EC 3.1.3.48), termed PTP2C, was isolated from a human umbilical cord cDNA library. The enzyme contains a single phosphatase domain and two adjacent copies of the src homology 2 (SH2) domain at its amino terminus. A variant of PTP2C (PTP2Ci) which has four extra amino acid residues within the catalytic domain has been identified also. PTP2C is widely expressed in human tissues and is particularly abundant in heart, brain, and skeletal muscle. The catalytic domain of PTP2C was expressed as a recombinant enzyme in Escherichia coli and purified to near homogeneity by two chromatographic steps. The recombinant enzyme was totally specific toward phosphotyrosine residues. The structural similarity between PTP2C and the previously described PTP1C suggests the existence of a subfamily of SH2-containing PTPs; these may play an important role in signal transduction through interaction of their SH2 domains with phosphotyrosine-containing proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681589      PMCID: PMC46053          DOI: 10.1073/pnas.90.6.2197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  SH2 and SH3 domains: from structure to function.

Authors:  T Pawson; G D Gish
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

2.  Purification and characterization of a human recombinant T-cell protein-tyrosine-phosphatase from a baculovirus expression system.

Authors:  N F Zander; J A Lorenzen; D E Cool; N K Tonks; G Daum; E G Krebs; E H Fischer
Journal:  Biochemistry       Date:  1991-07-16       Impact factor: 3.162

Review 3.  Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes.

Authors:  E H Fischer; H Charbonneau; N K Tonks
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

Review 4.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

5.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

6.  Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization.

Authors:  R L Huganir; A H Delcour; P Greengard; G P Hess
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

7.  Increase of the catalytic activity of phospholipase C-gamma 1 by tyrosine phosphorylation.

Authors:  S Nishibe; M I Wahl; S M Hernández-Sotomayor; N K Tonks; S G Rhee; G Carpenter
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

8.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.

Authors:  C A Koch; D Anderson; M F Moran; C Ellis; T Pawson
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

9.  Functional modulation of the nicotinic acetylcholine receptor by tyrosine phosphorylation.

Authors:  J F Hopfield; D W Tank; P Greengard; R L Huganir
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

10.  Structural diversity and evolution of human receptor-like protein tyrosine phosphatases.

Authors:  N X Krueger; M Streuli; H Saito
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

View more
  52 in total

1.  SHP-2 mediates target-regulated axonal termination and NGF-dependent neurite growth in sympathetic neurons.

Authors:  Bo Chen; Latanya Hammonds-Odie; Jeanette Perron; Brian A Masters; John L Bixby
Journal:  Dev Biol       Date:  2002-12-15       Impact factor: 3.582

2.  Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells.

Authors:  M Adachi; H Iwaki; M Shindoh; Y Akao; T Hachiya; M Ikeda; Y Hinoda; K Imai
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

3.  The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.

Authors:  Yi Zhan; George J Counelis; Donald M O'Rourke
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

Review 4.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

Review 5.  Protein tyrosine phosphatases in the JAK/STAT pathway.

Authors:  Dan Xu; Cheng-Kui Qu
Journal:  Front Biosci       Date:  2008-05-01

6.  Expression of PTPH1, a rat protein tyrosine phosphatase, is restricted to the derivatives of a specific diencephalic segment.

Authors:  M Sahin; S A Slaugenhaupt; J F Gusella; S Hockfield
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 7.  The biology of PECAM-1.

Authors:  P J Newman
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 8.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

9.  Stimulation by phospholipids of a protein-tyrosine-phosphatase containing two src homology 2 domains.

Authors:  Z Zhao; S H Shen; E H Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase.

Authors:  P Peraldi; Z Zhao; C Filloux; E H Fischer; E Van Obberghen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.